PharmEnable Therapeutics

Our number one priority at PharmEnable Therapeutics is to make a difference in patients’ lives. Thrilled to see that we featured in this Cambridge Enterprise article as one of the 10 Cambridge spinouts changing the story of cancer!

We are excited to celebrate Collaborative Drug Discovery - CDD Vault's 20 years of excellence tomorrow! As part of the event, our Director of Drug Discovery Dr James Dale will be discussing how we use our chemSEEK platform to reimagine small molecule drug discovery. We look forward to seeing many of you there!

We are honoured to be featured in Sifted as a techbio startup to watch, according to investors. Have a read to find out more https://lnkd.in/e5T-PhSF

Tomorrow, our Head of BD jessica iegre is attending the event "Increasing probability of R&D success with Casual AI" organised by PrecisionLife. The seminar is a unique opportunity for drug developers to learn about the application of our Causal AI to de-risk biopharma innovation and increase the probability of success at each stage of R&D. Look forward to seeing new and old faces!

Our Head of Business Development, Dr jessica iegre, and our Business and Scientific Analyst, Dr Dragana Mitic Potkrajac, are looking forward to seeing you at the Milner Therapeutics Symposium tomorrow. The Symposium is a key networking event and a great opportunity to discuss the latest research and how it could be applied in the pharma and biotech industry to develop new treatments. We are also presenting a poster - come and see us at poster no. 22! #MilnerSymp24 #DrugDiscovery #SmallMolecules

We are looking forward to participating in Cambridge Wide Open Day tomorrow! Dr jessica iegre, our Head of Business Development, will be speaking about innovative approaches to AI drug discovery at 12:30pm at Hauxton House. There are exciting events happening all over Cambridge, showcasing the city's world-class science and technology innovation. To find out more and plan your day, visit https://lnkd.in/gftZrJ4d.

We are looking forward to seeing you at the annual AstraZeneca Exchange event later today! A part of Cambridge Wide Open Day, this exciting event is celebrating the role of collaboration and mentoring in the growth of the UK life sciences ecosystem. Our CEO Dr Hannah Sore will discussing our highly collaborative approach to innovation.

Our CEO Dr Hannah Sore will be attending the Department for Business and Trade Health Tech Showcase event today, where she will discuss our approach to designing the next generation of small molecule drugs. This invitation-only event, held at the London Stock Exchange, highlights ten innovative UK health tech companies poised for international expansion. It provides an excellent opportunity for investors to connect with them and gain insights into their transformative work. #HealthTechShowcase #Innovation

We look forward to seeing you at BioTrinity this week! Our CEO Dr Hannah Sore will be sharing her insights into what it's like to be at the helm of one of the UK's leading life sciences R&D SMEs.    Join the discussion: https://lnkd.in/dmBez3G2    #BioTrinity #MedicinalChemistry #AIDrugDiscovery #DrugDiscovery 

Join us in welcoming our new non-executive director.   Dr Ian Collins, we are looking forward to working with you to push the boundaries of what is possible in the #SmallMolecule field for #oncology and #CNSdisease patients.   Read more about Ian: https://lnkd.in/eFhZTnUA   #DrugDiscovery #BoardMember #pharma #VentureCapital